Home/Cullgen/Ying Luo, Ph.D.

YL

Ying Luo, Ph.D.

Chairman, President and CEO

Therapeutic Areas

Oncology Pain Inflammatory Diseases

Cullgen Pipeline

Drug	Indication	Phase
CG001419	Pain	Phase 1

Leadership Team at Cullgen

Yue Xiong, Ph.D.

Chief Scientific Officer

Thomas Eastling

Chief Financial Officer

View full Cullgen profile